ARK Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-28
Closed -$2.66K 213
2019
Q1
$3K Sell
28
-174,275
-100% -$15.2M ﹤0.01% 196
2018
Q4
$11.2M Buy
174,303
+26,368
+18% +$1.95M 0.45% 40
2018
Q3
$13.2M Buy
147,935
+56,276
+61% +$4.97M 0.4% 50
2018
Q2
$7.28M Buy
91,659
+44,637
+95% +$3.71M 0.27% 59
2018
Q1
$4.2M Buy
47,022
+37,327
+385% +$3.58M 0.21% 62
2017
Q4
$1.01M Buy
9,695
+7,216
+291% +$814K 0.08% 98
2017
Q3
$361K Buy
2,479
+880
+55% +$120K 0.04% 119
2017
Q2
$208K Buy
1,599
+704
+79% +$86.3K 0.04% 96
2017
Q1
$111K Buy
895
+88
+11% +$10.5K 0.03% 92
2016
Q4
$93K Buy
+807
New +$89.9K 0.03% 90

Other funds holding CELG

ARK Investment Management's CELG Position: Q2 2019 in Review

ARK Investment Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 28 shares — an estimated $2.66K sold.

ARK Investment Management first reported a position in CELG in Q4 2016 and held it in 10 quarters. The position peaked at $13.2M in Q3 2018. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • ARK Investment Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • ARK Investment Management sold 28 Celgene Corp shares in Q2 2019, an estimated $2.66K.
  • ARK Investment Management first reported a position in Celgene Corp in Q4 2016 and held it in 10 quarters.
  • ARK Investment Management's Celgene Corp position peaked at $13.2M in Q3 2018.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on ARK Investment Management's 13F filing for Q2 2019, filed 30 Jul 2019.